Pharvaris N.V.

PHVS Nasdaq SEC CIK 1830487
Follow Pharvaris Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 EUR · IFRS
EPS, diluted -
Net income by quarter
−€29.7M
−€45.5M
Q2 24 Q2 25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income9 fiscal years
−€200M−€150M−€100M−€50M€0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−€175.7M
FY24−€134.2M
FY23−€100.9M
FY22−€76.3M
FY21−€42.7M
FY20−€26M
FY19−€8M
FY18−€4.3M
FY17-
Free cash flowOperating cash flow minus capital expenditure
−€150M−€100M−€50M€0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−€137.2M
FY24−€120.7M
FY23−€93.1M
FY22−€67.3M
FY21−€44.7M
FY20−€21.5M
FY19−€6.7M
FY18−€3.9M
FY17-